This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Pluristem Therapeutics

One under-$10 stock that's trading very close to triggering a near-term breakout trade is Pluristem Therapeutics (PSTI - Get Report), a bio-therapeutics company engaged in the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. This stock has been on fire so far in 2012, with shares up a whopping 60%.

>>4 Health Care Stocks Rising on Major Volume

If you take a look at the chart for Pluristem Therapeutics, you'll notice that this stock recently formed a double top at around $5 to $4.90 a share, after soaring from a low of $2.26 a share. Following that double top, shares of PSTI abruptly pulled back to its recent low of $3.65 a share. During that pullback, shares of PSTI were making lower highs and lower lows, which is bearish technical price action. That said, the stock has now started to rebound back above its 50-day moving average of $4 a share. That move is quickly pushing PSTI within range of triggering a near-term breakout trade.

Traders should now look for long-biased trades in PSTI as long as it's trending above its 50-day at $4, and then once it breaks out above some near-term overhead resistance at $4.28 a share with high volume. Look for a sustained move or close above $4.28 with volume that hits near or above its three-month average action of 1.4 million shares. If that breakout triggers soon, then PSTI will setup to re-test or possibly take out those double top price levels at $4.90 to $5 a share. Any high-volume move above $5 a share should setup PSTI to trend north of $6 a share.

Traders can now look to buy PSTI off weakness and simply use a stop somewhere below its 50-day moving average of $4 a share, or possibly around that recent low of $3.65 a share. A better strategy might be to buy off strength once PSTI takes out $4.28 a share with volume and then use a stop right around its 50-day.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ATEC $0.20 -12.00%
NSPH $0.78 1.80%
MWW $2.83 2.50%
NCQ $0.76 11.00%
PSTI $1.61 -0.62%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs